May 2, 2022 Senate Health and Welfare Committee Louisiana Senate 900 North Third Street Baton Rouge, Louisiana 70802 Dear Senator, On behalf of the 16,352 members and supporters of the Council for Citizens Against Government Waste (CCAGW) in Louisiana, I urge you to vote against HB548, which will make changes to the federal 340B drug discount […]
CCAGW Urges Senate Judiciary Committee to Oppose Expansion of Durbin Amendment
April 29, 2022 The Honorable Charles Grassley Ranking Member U.S. Senate Committee on the Judiciary Washington, D.C. 20510 Dear Senator Grassley, The Judiciary Committee is scheduled to hold a hearing Wednesday, May 4, 2022, titled “Excessive Swipe Fees and Barriers to Competition in the Credit and Debit Card Systems.” On behalf of the […]
CCAGW Urges Louisiana House of Representatives to Oppose HB548
April 26, 2022 House of Representatives Louisiana State Capitol 900 North Third Street Baton Rouge, Louisiana 70802 Dear Representative, On behalf of the 16,352 members and supporters of the Council for Citizens Against Government Waste (CCAGW) in Louisiana, I urge you to vote against HB548, which will make changes to the federal 340B drug discount program. […]
CAGW Joins 106 Signatories on Letter Spotlighting World IP Day
April 26, 2022 Dear Director-General Daren Tang, As a global coalition of 106 public policy organizations from 51 countries, we are pleased to celebrate World Intellectual Property Day alongside WIPO once again. This year’s theme, “IP and Youth: Innovating for a Better Future,” is particularly important as young people continue to be a driving force […]
CCAGW Urges Louisiana Senate to Oppose SB 32
April 8, 2022 Louisiana Senate State Capitol 900 North 3rd Street Baton Rouge, Louisiana 70804 Dear Senator, You will soon vote on SB 32. This legislation would impede and restrict pharmacy audits, making it more difficult to uncover and prevent waste, fraud, abuse, and mismanagement. On behalf of the 18,700 members and supporters of […]
CCAGW Urges House of Representatives to Oppose H.R. 3807
April 5, 2022 U.S. House of Representatives Washington, D.C. 20515 Dear Representative, You will soon be voting on H.R. 3807, the Restaurant Revitalization Fund (RRF) Replenishment Act of 2022. H.R. 3807 would authorize 5 billion in additional COVID-19 pandemic relief that is not offset and would add to the national debt. On behalf of […]
CCAGW Urges Oklahoma House of Representatives to Oppose SB 1860
April 1, 2022 Oklahoma House of Representatives 2300 North Lincoln Boulevard Oklahoma City, Oklahoma 73105 Dear Legislator, The House Public Health Committee will soon have a hearing on SB 1860. This legislation, should it become law, would impose onerous regulations on pharmacy benefit management and interfere with privately negotiated contracts among insurers, pharmaceutical benefit managers […]
CCAGW Urges House of Representatives to Oppose H.R. 6833
March 30, 2022 U.S. House of Representatives Washington, D.C. 20515 Dear Representative, You will soon be considering H.R. 6833, the Affordable Insulin Now Act. On behalf of the more than one million members and supporters of the Council for Citizens Against Government Waste (CCAGW), I urge you to oppose H.R. 6833 and any other measure […]
CCAGW Urges Rhode Island House State Government and Elections Committee to Oppose H 7917
March 29, 2022 Rhode Island House State Government & Elections Committee Rhode Island State Capitol 82 Smith Street Providence, Rhode Island 02903 Dear Representative, On behalf of the 4,845 members and supporters of the Council for Citizens Against Government Waste (CCAGW) in Rhode Island, I urge you to vote against H 7917, which seeks to protect […]
CCAGW Urges Missouri Senate Leadership to Oppose HB 1677
March 28, 2022 Missouri State Capitol 201 West Capitol Avenue Jefferson City, Missouri 65101 Dear Senator, On behalf of 38,548 members and supporters of the Council of Citizens Against Government Waste in Missouri, I urge you to oppose HB 1677. This legislation would create unnecessary regulatory barriers that will undermine the effectiveness of pharmaceutical benefit managers […]





